维普期刊资源整合服务平台（V6.5）

116篇 您的检索式：作者名="Gebski V"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	The effect of wating for radiotherapy for grade/ N gliomss显示文摘	Do V Gebski V Barton M	2000	Radiother Oncol2000，57，2：	1
2	A phase Ⅲ randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer显示文摘	Obermair A Gebski V Frumovitz M		0，，：	1
3	Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma:a meta-analysis and systematic review of the literature显示文摘	Baker J Obermair A Gebski V	2012	Gynecol Oncol2012，125，1：	1
4	Factors affecting epirubicin pharmacokinetics and toxicity:evidence against using body-surface area for dose calculation显示文摘	Gurney HP Ackland S Gebski V Farrell G		0，，：	1
5	Differential risk asse- ssments from five hypoxia specific assays: The basis for biologi- cally adapted individualized radiotherapy in advanced head an- d neck cancer patients显示文摘	Nordsmark M Eriksen JG Gebski V	2007	Radiother Oncol2007，83，3：	1
6	survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinomma:a meta-analysis显示文摘	Gebski V Burmeister B smithers BM	2007	Lancet Oncol2007，8，：	1
7	Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel-ANZGOG显示文摘	Tinker AV Gebski V Fitzharris B	2007	Gyneeol Oncol2007，104，3：	1
8	Phase Ⅱ trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel显示文摘	Tinke AV Gebski V Fitzharris B	2007	Gynecol Oncol2007，104，3：	1
9	Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma:a meta-analysis and systematic review of the literature 显示文摘	Baker J Obermalr A Gebski V	2012	Gynecol Oncol2012，125，1：	1
10	Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oeso- phageal carcinoma: a meta-analysis显示文摘	Gebski V Burmeister B Smithers BM	2007	Lancet Oncol2007，8，3：	1
11	Secondary cytoreductive surgery for recurrent epithelial ovarian cancer 显示文摘	Tay EH Grant PT Gebski V	2002	Obstet Gynecol2002，99，：	1
12	Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: A Meta - analysis 显示文摘	Gebski V Burmeister B Smithers BM	2007	Lancet2007，8，3：	1
13	A phase Ⅲ randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer显示文摘	Obermair A Gebski V Frumovitz M	2008	J Mini Invas Gynecol2008，15，：	1
14	Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma:a meta-analysis显示文摘	Gebski V Burmeister B Smithers BM	2007	Lancet Oncol2007，8，3：	1
15	The effect of waiting for radiotherapy for grade Ⅲ/Ⅳ gliomas显示文摘	Do V Gebski V Barton M B	2000	Radiother Oncol2000，57，4：	1
16	The utility of serum CA125 in predicting extra uterine disease in apparent early stage endometrial cancer显示文摘	Nicklin J Janda M Gebski V	2012	Int J Cancer2012，131，4：	1
17	Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early en- dometrial adenocarcinoma:a meta-analysis and system- atic review of the literature显示文摘	Baker J Obermair A Gebski V et d	2012	Gynecologic Oncol2012，125，1：	1
18	Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer 显示文摘	Green MD Francis PA Gebski V	2009	Ann Oncol2009，20，11：	1
19	Differential risk assessments from five hypoxia specific assays:The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients显示文摘	Nordsmark M Eriksen JG Gebski V	2007	Radiother Oncol2007，83，3：	1
20	Secondary cytoreductive surgery for recurrent epithelial ovarian cancer显示文摘	TAY EH GRANT PT GEBSKI V	2002	Obstet Gynecol2002，99，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示